Breast Cancer Clinical Trial

Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer

Summary

The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

A confirmed histological diagnosis of invasive breast carcinoma or DCIS
Age greater or equal to 50 years old
Life expectancy > 6 months
Treated by breast conserving surgery with axillary node dissection or sentinel lymph node biopsy
Pathologic tumor size less than or equal to 2 cm
Invasive ductal, mucinous, tubular or colloid histology
Estrogen receptor positive for invasive carcinoma.
Unifocal/unicentric disease
Negative surgical margins greater than or equal to 2 mm
Pathologic lymph node negative
No evidence of lymphovascular invasion
ECOG performance status of 0 or 1 (Appendix 1)
Informed consent signed.

Exclusion Criteria:

Known BRCA 1/2 Mutation; (BRCA 1 and 2 testing is not required)
Autoimmune disorder
Pregnancy
Breast implants
Psychiatric or addictive disorder that would preclude attending follow-up
Neoadjuvant chemotherapy (adjuvant chemotherapy is permitted)
Suspicious remaining microcalcification on post-surgery mammogram (unless biopsy proven benign)
Lobular features on histology (pure or mixed) or sarcoma histology
Node positive on axillary dissection or in the sentinel lymph node biopsy;
Extensive in situ carcinoma (EIC)
Multicentric or multifocal disease
Paget's disease of the nipple
Distant metastases
Lumpectomy cavity not well visualized on AccuBoost imaging
Lumpectomy cavity with 1cm margin (PTV) not adequately encompassed by any applicator (PTV > 6cm)
Breast separation with compression > 7cm.
Overlap of skin between orthogonal treatment axes.

Study is for people with:

Breast Cancer

Estimated Enrollment:

40

Study ID:

NCT01463007

Recruitment Status:

Completed

Sponsor:

Jaroslaw Hepel

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Center For Cancer Care and Research- Watson Clinic
Lakeland Florida, 33805, United States
Brown University Oncology Research Group
Providence Rhode Island, 02903, United States
Lifespan Hospitals
Providence Rhode Island, 02903, United States
Tacoma Radiation
Tacoma Washington, 98405, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

40

Study ID:

NCT01463007

Recruitment Status:

Completed

Sponsor:


Jaroslaw Hepel

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider